|
Coleman pregunto:
Not in at the moment <a href=" http://ecrengines.com/index.php?should-governments-shoulder-the-cost-of-developing-drugs-that-are-designed-to-help-only-a.pptx#surgeon ">generic pharmaceutical names</a> The maker of glass products reported second-quarter earningslower than analysts´ estimates. The company also raised itsfull-year earnings forecast to between 93 cents and $1 per sharefrom 90 cents to $1 per share. Analysts on average expectearnings of 96 cents per share, according to Thomson ReutersI/B/E/S. |
|
|
|
